Anna Erkstam

Anna Erkstam has a diverse work experience in scientific and executive roles. Anna is currently the Chief Executive Officer at BioReperia, a position they have held since June 2022. Prior to that, they served as the Chief Operating Officer from January 2019 to June 2022 and as the Chief Scientific Officer from February 2017 to January 2019, both at BioReperia.

Before joining BioReperia, Anna worked at CTC Clinical Trial Consultants AB as the SMO Development Coordinator from January 2017 to August 2017.

Anna's earlier experience includes their time at Linköping University, where they worked as a PhD student from June 2010 to December 2016 and as a Research Assistant from October 2008 to June 2010.

Anna Erkstam completed their education at Linköping University. From 2004 to 2008, they earned a Master of Science degree in Medical Biology. Anna then went on to pursue a Doctor of Philosophy (PhD) in Neurobiology and Neurosciences at Linköping University from 2010 to 2016.